Human/Mouse Otoraplin/OTOR Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3979
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Val18-Glu128
Accession # Q9NRC9
Specificity
Clonality
Host
Isotype
Applications for Human/Mouse Otoraplin/OTOR Antibody
Western Blot
Sample: Recombinant Human and Mouse Otoraplin/OTOR
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Otoraplin/OTOR
Otoraplin (OTOR), also known as fibrocyte-derived protein (Fdp) and Melanoma inhibitory activity-like (MIAL), is a secreted 16 kDa globular protein that is preferentially expressed in the inner ear by periotic mesenchyme and developing and mature fibrocytes. It is highly homologous to MIA/cartilage-derived retinoic acid‑sensitive protein (CD-RAP), which is a cartilage-specific protein that is also expressed in malignant melanoma cells. The 111 amino acid residue (aa) mature human otoraplin contains one SH3 domain (aa 46‑107) and a Tyr at position 50 that is reportedly sulfated. Otoraplin is reported to play a role in the initiation of periotic mesenchyme chondrogenesis. Mature human Otoraplin shares 91% and 89% aa sequence identity with canine and mouse Otoraplin, respectively.
Alternate Names
Gene Symbol
UniProt
Additional Otoraplin/OTOR Products
Product Documents for Human/Mouse Otoraplin/OTOR Antibody
Product Specific Notices for Human/Mouse Otoraplin/OTOR Antibody
For research use only